Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone…

Prakash A, Goa KL. BioDrugs 1999

Document identifier
CEI-BR-089
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
Prakash A, Goa KL
Title
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
Source
BioDrugs
Year
1999
Volume, issue, pages
12(2):139–157
Digital object identifier
10.2165/00063030-199912020-00007
PubMed identifier
18031173
Record type
Journal article
Institute identifier
CEI-BR-089

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

§1.3Subject tags

sermorelin clinical ghrh

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.